Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Filtration Plasmapheresis (DFPP) in Combination With Pegylated Interferon Alfa-2a and Ribavirin for Patients With Chronic Hepatitis C With Genotype 1 and High Viral Load: a Randomized Controlled Trial

NCT00977054 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00977054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00977054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Filtration Plasmapheresis (DFPP) in Combination With Pegylated Interferon Alfa-2a and Ribavirin for Patients With Chronic Hepatitis C With Genotype 1 and High Viral Load: a Randomized Controlled Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2009
Completion date
December 31, 2012
Enrollment
59 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c